ErbB receptor tyrosine kinase family expression levels in urothelial bladder carcinoma
Yazarlar (6)
Prof. Dr. Sezgin Güneş Ondokuz Mayıs Üniversitesi, Türkiye
Prof. Dr. Yurdanur Süllü Ondokuz Mayıs Üniversitesi, Türkiye
Doç. Dr. Zeynep YEĞİN Sinop Üniversitesi, Türkiye
Recep Büyükalpelli
Ondokuz Mayıs Üniversitesi, Türkiye
Prof. Dr. Leman Tomak Ondokuz Mayıs Üniversitesi, Türkiye
Arş. Gör. Hasan Bağcı Ondokuz Mayıs Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Pathology Research and Practice (Q3)
Dergi ISSN 0344-0338 Dergi Bilgileri (2013)
Dergi Tarandığı Indeksler SCI
Makale Dili İngilizce Basım Tarihi 02-2013
Kabul Tarihi – Yayınlanma Tarihi 01-02-2013
Cilt / Sayı / Sayfa 209 / 2 / 99–104 DOI 10.1016/j.prp.2012.10.014
Makale Linki https://linkinghub.elsevier.com/retrieve/pii/S0344033812003044
UAK Araştırma Alanları
Tıbbi Biyoloji
Özet
ErbB receptor tyrosine kinases family plays an important role in cell cycle regulation. Overexpression of ErbB receptors has been described in several solid tumors. The aim of this study was to investigate the levels of ErbB1, ErbB2, ErbB3, and ErbB4 expression in bladder cancer. Urinary bladder tumor samples were obtained from 33 bladder cancers and 7 non-cancerous bladder biopsies. The levels of ErbB1, ErbB2, ErbB3, and ErbB4 genes expression in bladder cancer were determined by real-time PCR. The presence of protein was confirmed by immunostaining. Expression of ErbB1, ErbB2, ErbB3, and ErbB4 genes increased 0.67, 4.72, 2.89, and 2.65-fold, respectively, in bladder tumors as compared with normal tissue. There was a significant difference between immunostaining results of ErbB4 protein in bladder tumors and normal bladder tissue (P<0.01). The present data suggest that ErbB2, ErbB3, and …
Anahtar Kelimeler
ERBB1-4 gene | Gene expression | Urothelial bladder carcinoma
Science Direct
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 9
Scopus 11
Google Scholar 16
ErbB receptor tyrosine kinase family expression levels in urothelial bladder carcinoma